现代科学仪器2023，Vol.40Issue(6)：53-57,5.
PG1/PG2与肿瘤标志物预测中晚期胃癌近期生存
Prediction of PG1/PG2 and tumor markers on short-term survival in advanced gastric cancer
摘要
Abstract
Objective:To analyze the value of analyzing serum PG1/PG2,CEA,and CA125 in predicting short-term survival of advanced gastric cancer.Methods:110 patients with advanced gastric cancer and 110 healthy volunteers were selected.Serum PG1,PG2,CEA,CA125 were detected,and the patients were followed up for 1 year.Results:Serum PG1/PG2 in the cancer group was lower(P<0.05),while CEA and CA125 levels were higher(P<0.05),all of which were related to gastric cancer stage,pathological types and recent survival(P<0.05).The combined prediction of serum PG1/PG2,CEA and CA125 had a higher AUC(P<0.05).Conclusion:The decrease of serum PG1/PG2 and the increase of CEA and CA125 in advanced gastric cancer are related to clinical pathological characteristics,and the combined prediction of short-term survival has high value.关键词
胃蛋白酶原1/胃蛋白酶原2/癌胚抗原/糖类抗原125/胃癌/生存Key words
Pepsinogen 1/Pepsinogen 2/Carcinoembryonic antigen/Carbohydrate antigen 125/Gastric cancer/Survival分类
医药卫生引用本文复制引用
盛超,王俊先,黄家惠,刘冬,徐娟,李绍雪..PG1/PG2与肿瘤标志物预测中晚期胃癌近期生存[J].现代科学仪器,2023,40(6):53-57,5.基金项目
2021年度安徽省卫生健康委科研项目AHWJ2021b094 （）
